By all conventional measures, Americans should already be healthier.
The knowledge is everywhere. People know they should eat better, sleep better, exercise more, and reduce stress. The science is not hidden. The problem is not awareness. The problem is execution.
That is the thesis at the heart of Lionheart Health’s rise—and one of the reasons its recent No. 1 ranking carries significance beyond a single company milestone. In a sector crowded with diagnostics, apps, supplements, and wellness promises, Lionheart Health has been advancing a more practical idea: that the next generation of healthspan leaders will not win merely by telling people what to do, but by building technologies, protocols, and delivery systems that help people actually do better in the real world.
“If knowledge alone created health, America would already be extremely healthy, because most people already know they should eat better, sleep better, exercise, and reduce stress,” said Howard Leonhardt, Executive Chairman of Lionheart Health, Inc. “The real barrier is not awareness but behavior, because lasting habit change is one of the hardest things humans do, especially when stress, pain, aging, poor sleep, and modern convenience are all pushing in the opposite direction. That is why healthspan technology matters: it helps reduce the burden on willpower by making healthy outcomes easier, more measurable, more personalized, and more achievable in real life.”
It is a statement that helps explain not only Lionheart Health’s strategy, but also the broader market opportunity unfolding around health optimization, regenerative wellness, and personalized healthspan technologies. In Leonhardt’s view, the biggest bottleneck in modern health is not information scarcity. It is the gap between intention and sustained action.
“Americans do not suffer from a lack of health knowledge—they suffer from the difficulty of sustained behavior change,” Leonhardt said. “The biggest bottleneck in healthspan is not knowing what to do; it is doing it consistently in the real world. The winning healthspan technologies will be those that reduce dependence on willpower and make better biological outcomes easier, more reliable, and more scalable.”
That philosophy has increasingly shaped Lionheart Health’s commercial and scientific direction. The company has positioned itself at the intersection of health optimization, bioelectric stimulation, regenerative wellness, and personalized protocol design, with a growing focus on technologies intended to improve not just insight, but outcomes. Its broader message is that healthspan interventions must move beyond aspiration and into repeatable, measurable, user-friendly systems that support the body more directly.
That vision is also informing Lionheart Health’s ongoing out-of-U.S. research initiatives. Among the more notable is its work in enhanced peptide delivery, where the company is applying patented bioelectric stimulation sequence protocols in studies designed to improve IV and direct injection Klotho peptide delivery and tissue uptake in the kidney, brain, and muscle. The premise is not necessarily that systemic peptide levels must always rise, but that local uptake, cellular internalization, and biological response in target tissues may be improved through complementary bioelectric mechanisms.
Those mechanisms include increased cellular membrane permeability, electrophoretic peptide transport, microcirculation and perfusion enhancement, signaling effects that may improve tissue responsiveness to Klotho-related pathways, and increased endocytosis and vesicle uptake. Taken together, the work reflects a larger Lionheart Health thesis: in the future of regenerative and healthspan medicine, success may depend as much on preparing the body to receive and respond to therapeutics as on the therapeutics themselves.
That is part of what makes the company’s No. 1 ranking feel like more than symbolic recognition.
For Lionheart Health, the ranking serves as an external validation of years of work spent building a platform around the idea that healthspan innovation must be practical, scalable, and biologically meaningful. For investors, it may signal growing market credibility. For strategic partners, it may sharpen interest in collaboration. For patients and consumers, it may reinforce confidence that the company is emerging as a serious player in the future of personalized health optimization.
And for Leonhardt, the meaning is both personal and strategic.
“To be ranked No. 1 is both deeply humbling and profoundly validating,” he said. “It is recognition that the work we have poured our lives into is being seen, respected, and measured at the highest level. For Lionheart Health, this ranking is more than an honor—it is a signal to the world that we are emerging as a category leader in health optimization, regenerative wellness, and bioelectric-enhanced health technologies.”
He added: “Being No. 1 is not the finish line. It is a call to rise even higher.”
That may ultimately be the most telling part of the moment. The ranking celebrates what Lionheart Health has achieved. But the company appears intent on using it as a springboard—into deeper scientific validation, broader commercialization, stronger financial momentum, expanded strategic relationships, and a larger role in shaping what the next decade of healthspan medicine could look like.
In that sense, the news is not simply about being recognized as No. 1.
It is about what Lionheart Health believes comes next.
Copyright © 2026 California Business Journal. All Rights Reserved.
For California Business Journal Disclaimers, go to /terms-conditions/.
Editor's note: The No. 1 ranking of Healthspan Longevity Membership Programs comes from The California Business Journal Editors Panel based on what was meant to be an un-biased scoring system focused on validity of science, pre-clinical and clinical supporting data, patents, offerings, experience of team, awards and recognitions, publications, scope and progress using an AI analysis engine. The scoring chart and methodology can be shared with anyone that requests a copy.
